• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保健行业首次公开募股(IPO)与股权再融资(SEO)的实证分析

An empirical analysis of health care IPOs and SEOs.

作者信息

Brau James C, Holloway Jonathan M

机构信息

Brigham Young University, Marriott School, Department of Finance, USA.

出版信息

J Health Care Finance. 2009 Summer;35(4):42-63.

PMID:20515009
Abstract

This article reviews the extant literature regarding the three new issues phenomena: hot issue markets, first-day underpricing, and poor long-run performance as they apply to the heath care industry. Given the "creeping corporatization" of the heath care industry and the unique influence of nonmarket forces on it, we examine whether the three IPO phenomena exist within the industry. We find that hot issue markets, initial underpricing, and negative long-run abnormal returns and sales growth occur among both heath care IPOs and SEOs. Of particular interest, we find that firms are able to issue during times of excess heath care spending and subsequently underperform the market, apparently exploiting windows of opportunity.

摘要

本文回顾了有关三种新发行现象的现有文献

热门发行市场、首日抑价以及适用于医疗保健行业的长期不佳表现。鉴于医疗保健行业的“渐进式公司化”以及非市场力量对其的独特影响,我们研究了这三种首次公开募股现象是否存在于该行业中。我们发现,热门发行市场、首次抑价以及长期负异常回报和销售增长在医疗保健行业的首次公开募股和增发中均有出现。特别值得关注的是,我们发现企业能够在医疗保健支出过剩时期进行发行,随后表现逊于市场,这显然是在利用机会窗口。

相似文献

1
An empirical analysis of health care IPOs and SEOs.医疗保健行业首次公开募股(IPO)与股权再融资(SEO)的实证分析
J Health Care Finance. 2009 Summer;35(4):42-63.
2
Aftermarket Performance of Health Care and Biopharmaceutical IPOs: Evidence From ASEAN Countries.医疗保健和生物制药首次公开募股的后市表现:来自东盟国家的证据。
Inquiry. 2017 Jan 1;54:46958017727105. doi: 10.1177/0046958017727105.
3
Trends in biopharmaceutical IPOS: 1996-2005.生物制药行业首次公开募股趋势:1996 - 2005年
J Health Care Finance. 2006 Winter;33(2):39-54.
4
Vulnerability of health to market forces.健康易受市场力量影响。
Med Care. 2011 Mar;49(3):232-9. doi: 10.1097/MLR.0b013e31820ab638.
5
Do governance, equity characteristics, and venture capital nvolvement affect long-term wealth creation in U.S. health care and biotechnology IPOs?
J Health Care Finance. 2006 Fall;33(1):54-71.
6
Still golden? More companies eyeing healthcare, but newcomers need to deliver real value.依旧金光闪闪?更多公司觊觎医疗保健领域,但新进入者需创造真正价值。
Mod Healthc. 2011 Jun 27;41(26):20.
7
The economics of hospital reform: from hierarchical to market-based incentives.医院改革的经济学:从层级激励到基于市场的激励
World Hosp Health Serv. 2003;39(3):3-10, 42, 44.
8
On a smaller scale. Boutique investment firms ready to feed a hungry market.
Mod Healthc. 2001 Jan 8;31(2):60, 63.
9
Seven guidelines for approaching the new growth mandate.
Healthc Strateg. 1999 Mar;3(3):1-6.
10
Market orientation in the hospital industry.
Mark Health Serv. 1997 Winter;17(4):36-45.

引用本文的文献

1
Aftermarket Performance of Health Care and Biopharmaceutical IPOs: Evidence From ASEAN Countries.医疗保健和生物制药首次公开募股的后市表现:来自东盟国家的证据。
Inquiry. 2017 Jan 1;54:46958017727105. doi: 10.1177/0046958017727105.